Glasgow, United Kingdom
Sistemic Ltd, founded in 2009 and headquartered in the United Kingdom, pioneers in integrating microRNA (miRNA) for advanced cell therapy characterization. The company's slogan, "MicroRNA-based services for advanced cell therapy characterization," succinctly encapsulates its mission. Sistemic operates within the vital sectors of Biotechnology, Health Care, and Pharmaceutical markets.
By focusing on miRNA's potential as "master controllers of a cell," the firm delivers a systems approach through its proprietary Sistemic Methodology. This includes robust miRNA profiling, superior statistical analytics, and multi-layered contextual analysis—yielding knowledge-rich data indicative of broad biological effects rather than isolated pathways.
The company's most recent investment was a $1.00M Series A round in March 2010, led by Chimera Bioengineering. As such, Sistemic Ltd presents an intriguing prospect for investors focused on innovative, data-rich solutions in the biopharmaceutical landscape.
